Skip to main content
SpringerLink
Log in

Procoagulant activity and intimal dysfunction in IDDM

  • Originals
  • Published:
Diabetologia Aims and scope Submit manuscript

Summary

The biological activity of thrombin and coagulation factor Xa was assessed in 62 insulin-dependent diabetic patients. A group of non-diabetic subjects of comparable age and urinary albumin excretion rate (<30 mg/24 h) served as control subjects (group 1,n=14). The patients were divided into three groups according to urinary albumin excretion rate. In group 2, albumin excretion rate was less than 30 mg/24 h (n=17), in group 3 albumin excretion rate was in the range 30–300 mg/24 h (n=20) and in group 4 albumin excretion rate was greater than 300 mg/24 h (n=25). Compared to non-diabetic control subjects an increase in the biological activity of factor Xa was observed in all groups of diabetic patients (prothrombin fragment 1+2 levels were 1.14±0.38 nmol/l in group 2,p<0.005; 1.06±0.45 nmol/l in group 3,p<0.05 and 1.03±0.31 nmol/l in group 4,p<0.05 vs 0.75±0.34 nmol/l in group 1). No difference in the level of antithrombin III was seen between the groups. We reconfirmed the presence of intimal dysfunction in diabetic nephropathy demonstrated by elevated transcapillary escape rate of albumin in group 4 compared with group 2 (8.9±2.0% vs 7.0±1.9%,p<0.05). An overall positive correlation between transcapillary escape rate and prothrombin fragment 1+2 was found (r=0.36,p<0.005). However, in the groups with elevated albumin excretion rate such a correlation was not significant (group 3:r=0.15,p=0.54; group 4:r=0.03,p=0.86) while it was sustained in the groups with albumin excretion rate of less than 300 mg/24 h (group 1:r=0.61,p<0.05; group 2:r=0.64,p<0.05). In conclusion, IDDM patients had elevated biological activity of factor Xa, demonstrated by elevated levels of prothrombin fragment 1+2. This increment could not be explained by a deficiency of antithrombin III. [Diabetologia (1995) 38: 73–78]

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

IDDM:

Insulin-dependent diabetes mellitus

TER:

transcapillary of albumin

(vWf:Ag):

von Willebrond Factor

TAT:

thrombin-antithrombin III complexes

References

  1. Borch-Johnsen K, Kreiner S (1987) Proteinuria — a predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. BMJ 294: 1651–1654

    CAS  PubMed  Google Scholar 

  2. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30: 144–148

    Article  CAS  PubMed  Google Scholar 

  3. Jensen T, Stender S, Deckert T (1988) Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31: 142–145

    Article  CAS  PubMed  Google Scholar 

  4. Lipid Research Clinics Program (1984) The lipid Research Clinics Coronary Primary Prevention Trial Results. JAMA 251: 351–374

    Google Scholar 

  5. Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M (1988) Glomerular size and charge selectivity in type 1 (insulin-dependent) diabetes mellitus. Kidney Int 33: 100–106

    CAS  PubMed  Google Scholar 

  6. Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M (1987) Glomerular size and charge selectivity in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 513A (Abstract)

    Google Scholar 

  7. Deckert T, Kofoed-Enevoldsen A, Vidal P, Nørgaard K, Andreasen HB, Feldt-Rasmussen B (1993) Size- and charge selectivity of glomerular filtration in type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36: 244–251

    Article  CAS  PubMed  Google Scholar 

  8. Klein DJ, Oegema TR, Brown DM (1989) Release of glomerular heparan 35-SO4 proteoglycan by heparin from glomeruli of streptozotocin-induced diabetic rats. Diabetes 38: 130–139

    CAS  PubMed  Google Scholar 

  9. Kanwar YS, Rosenzweig LJ, Linker A, Jakubowski ML (1983) Decreased de novo synthesis of glomerular proteoglycans in diabetes. Proc Natl Acad Sci USA 80: 2272–2275

    CAS  PubMed  Google Scholar 

  10. Rorbach R (1986) Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the glomerular basement membrane. Virchows Arch B Cell Pathol 51: 127–135

    Google Scholar 

  11. Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell J (1990) Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthetase inhibition. Diabetes 39: 196–203

    CAS  PubMed  Google Scholar 

  12. Kanwar YS, Linker A, Farquhar MG (1980) Increased permeability of the glomerular membrane to ferritin after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J Cell Biol 86: 688–693

    Article  CAS  PubMed  Google Scholar 

  13. Bourin M-C, Lindahl U (1993) Glycosaminoglycans and the regulation of blood coagulation. Biochem J 289: 313–330

    CAS  PubMed  Google Scholar 

  14. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219–226

    CAS  PubMed  Google Scholar 

  15. Parving H-H, Rasmussen SM (1973) Transcapillary escape rate of albumin and plasma volume in short- and longterm juvenile diabetics. Scand J Clin Lab Invest 32: 81–87

    CAS  Google Scholar 

  16. Bröchner-Mortensen J (1972) A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30: 271–274

    PubMed  Google Scholar 

  17. Svendsen PA, Christiansen JS, Søegaard U, Welinder BS, Nerup J (1980) Rapid changes in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentrations. Diabetologia 19: 130–136

    Article  CAS  PubMed  Google Scholar 

  18. Feldt-Rasmussen B, Dinesen B, Deckert M (1985) Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45: 539–544

    CAS  PubMed  Google Scholar 

  19. Pelzer H, Schwarz A, Stüber W (1991) Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemostas 65: 153–159

    CAS  Google Scholar 

  20. Soria J, Soria C, Ryckewaert JJ (1980) A solid phase immuno enzymological assay for the measurement of human fibrinopeptide A. Thromb Res 20: 425–435

    Article  CAS  PubMed  Google Scholar 

  21. Gram J, Jespersen J (1989) Increased concentrations of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin III. Clin Chem 35: 52–55

    CAS  PubMed  Google Scholar 

  22. Ingerslev J (1987) A sensitive ELISA for von Willebrand factor (vW:Ag). Scand J Clin Lab Invest 47: 143–149

    CAS  PubMed  Google Scholar 

  23. Blombäck B, Blombäck M (1956) Preparation of human fibrinogen fraction 1–2. Arkiv Kemi 10: 415–443

    Google Scholar 

  24. Pelzer H, Schwartz A, Heimburger N (1988) Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 59: 101–106

    CAS  Google Scholar 

  25. Bauer KA, Goodman TL, Kass BL, Rosenberg RD (1985) Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. J Clin Invest 76: 826–836

    CAS  PubMed  Google Scholar 

  26. Rosove MH, Harrison JL, Frank JL, Harwig SSL (1984) Plasma β-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus. Diabetes Care 7: 174–179

    CAS  PubMed  Google Scholar 

  27. Haaber AB, Deckert M, Stender S, Jensen T (1993) Increased urinary loss of high density lipoproteins in albuminuric insulin-dependent diabetic patients. Scand J Clin Lab Invest 53: 191–196

    CAS  PubMed  Google Scholar 

  28. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Bruna A, Pagano G (1993) Haemostatic alterations in microalbuminuric insulin-dependent diabetic patients. Diabetologia 36 [Suppl 1]: A215 (Abstract)

    Google Scholar 

  29. Ceriello A, Giacomello R, Colatutto A, Taboga C, Gonano F (1992) Increased prothrombin fragment 1+2 in type 1 diabetic patients. Haemostasis 22: 50–51

    CAS  PubMed  Google Scholar 

  30. Ceriello A (1993) Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36: 1119–1125

    CAS  PubMed  Google Scholar 

  31. Rohrbach DH, Hassel JR, Kleinman HK, Martin GR (1982) Alterations in the basement membrane (heparan sulphate) proteoglycans in diabetic mice. Diabetes 31: 185–188

    CAS  PubMed  Google Scholar 

  32. Parthasarathy N, Spiro RG (1982) Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31: 738–741

    CAS  PubMed  Google Scholar 

  33. Feldt-Rasmussen B (1986) Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29: 282–286

    Article  CAS  PubMed  Google Scholar 

  34. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T (1989) Features of endothelial dysfunction in early diabetic nephropathy. Lancet i: 461–463

    Google Scholar 

  35. Jensen T (1989) Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy. BMJ 298: 27–28

    CAS  PubMed  Google Scholar 

  36. Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD (1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans. J Clin Invest 80: 1527–1534

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Thrombosis Research, South Jutland University Center, Esbjerg, Denmark

    J. Gram & J. Jespersen

  2. The Gaubius Laboratory, PG-TNO, Leiden, The Netherlands

    C. Kluft

  3. Steno Diabetes Center, Niels Steensens Vej 2, DK-2820, Gentofte, Denmark

    B. Myrup, P. Rossing & T. Jensen

Authors
  1. B. Myrup
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Rossing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Gram
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Kluft
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Jespersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Myrup, B., Rossing, P., Jensen, T. et al. Procoagulant activity and intimal dysfunction in IDDM. Diabetologia 38, 73–78 (1995). https://doi.org/10.1007/BF02369355

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02369355

Key words

Search

Navigation